Sheila Lezcano

586 total citations
8 papers, 440 citations indexed

About

Sheila Lezcano is a scholar working on Gastroenterology, Nutrition and Dietetics and Surgery. According to data from OpenAlex, Sheila Lezcano has authored 8 papers receiving a total of 440 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Gastroenterology, 3 papers in Nutrition and Dietetics and 2 papers in Surgery. Recurrent topics in Sheila Lezcano's work include Gastrointestinal motility and disorders (7 papers), Clinical Nutrition and Gastroenterology (2 papers) and Infant Health and Development (2 papers). Sheila Lezcano is often cited by papers focused on Gastrointestinal motility and disorders (7 papers), Clinical Nutrition and Gastroenterology (2 papers) and Infant Health and Development (2 papers). Sheila Lezcano collaborates with scholars based in United States. Sheila Lezcano's co-authors include Mark Pimentel, Sun‐Chuan Dai, Reza Khoshini, Kimberly Low, Walter Morales, Jeffrey L. Conklin, E. E. Soffer, Ruchi Mathur, David C. Kunkel and Benjamin Basseri and has published in prestigious journals such as The American Journal of Gastroenterology, Digestive Diseases and Sciences and Neurogastroenterology & Motility.

In The Last Decade

Sheila Lezcano

8 papers receiving 431 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sheila Lezcano United States 6 296 197 107 92 62 8 440
Reza Khoshini United States 3 234 0.8× 152 0.8× 80 0.7× 87 0.9× 42 0.7× 5 350
Siegfried Yu United States 8 269 0.9× 180 0.9× 101 0.9× 108 1.2× 27 0.4× 16 476
Juan José Sebastián Domingo Spain 11 177 0.6× 105 0.5× 55 0.5× 98 1.1× 49 0.8× 31 382
François Dyard France 10 232 0.8× 227 1.2× 94 0.9× 97 1.1× 18 0.3× 15 552
Carlos Defilippi Chile 12 268 0.9× 276 1.4× 152 1.4× 118 1.3× 37 0.6× 24 726
Cindy James Canada 8 193 0.7× 164 0.8× 45 0.4× 92 1.0× 64 1.0× 9 420
Paolo Andreozzi Italy 14 252 0.9× 227 1.2× 74 0.7× 45 0.5× 22 0.4× 31 562
Anna Maria Magistà Italy 8 327 1.1× 285 1.4× 36 0.3× 103 1.1× 30 0.5× 9 532
Sean Bennet Sweden 8 348 1.2× 104 0.5× 150 1.4× 206 2.2× 51 0.8× 12 469
Jari Koskenpato Finland 14 485 1.6× 431 2.2× 97 0.9× 102 1.1× 62 1.0× 21 791

Countries citing papers authored by Sheila Lezcano

Since Specialization
Citations

This map shows the geographic impact of Sheila Lezcano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sheila Lezcano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sheila Lezcano more than expected).

Fields of papers citing papers by Sheila Lezcano

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sheila Lezcano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sheila Lezcano. The network helps show where Sheila Lezcano may publish in the future.

Co-authorship network of co-authors of Sheila Lezcano

This figure shows the co-authorship network connecting the top 25 collaborators of Sheila Lezcano. A scholar is included among the top collaborators of Sheila Lezcano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sheila Lezcano. Sheila Lezcano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Kunkel, David C., Benjamin Basseri, Kimberly Low, et al.. (2011). Efficacy of the glucagon-like peptide-1 agonist exenatide in the treatment of short bowel syndrome. Neurogastroenterology & Motility. 23(8). 739–e328. 60 indexed citations
2.
Pimentel, Mark, Laura Hwang, Gil Melmed, et al.. (2009). New Clinical Method for Distinguishing D-IBS from Other Gastrointestinal Conditions Causing Diarrhea: The LA/IBS Diagnostic Strategy. Digestive Diseases and Sciences. 55(1). 145–149. 26 indexed citations
3.
Pimentel, Mark, et al.. (2009). Low-dose nocturnal tegaserod or erythromycin delays symptom recurrence after treatment of irritable bowel syndrome based on presumed bacterial overgrowth.. PubMed. 5(6). 435–42. 27 indexed citations
4.
Khoshini, Reza, Sun‐Chuan Dai, Sheila Lezcano, & Mark Pimentel. (2007). A Systematic Review of Diagnostic Tests for Small Intestinal Bacterial Overgrowth. Digestive Diseases and Sciences. 53(6). 1443–1454. 229 indexed citations
5.
Pimentel, Mark, Soumya Chatterjee, Christopher Chang, et al.. (2007). A New Rat Model Links Two Contemporary Theories in Irritable Bowel Syndrome. Digestive Diseases and Sciences. 53(4). 982–989. 69 indexed citations
6.
Pimentel, Mark & Sheila Lezcano. (2007). Irritable bowel syndrome: Bacterial overgrowth—What’s known and what to do. Current Treatment Options in Gastroenterology. 10(4). 328–337. 26 indexed citations
7.
Pimentel, Mark, Benjamin Basseri, Sheila Lezcano, et al.. (2007). The Efficacy of the GLP-1 Agonist Exenatide in the Treatment of Short Bowel Syndrome. The American Journal of Gastroenterology. 102. S201–S202. 1 indexed citations
8.
Pimentel, Mark, Soumya Chatterjee, Christopher Chang, et al.. (2006). Gastrointestinal Infection with Campylobacter jejuni 81–176 Produces Altered Bowel Function and Bacterial Overgrowth in Rats. The American Journal of Gastroenterology. 101. S472–S472. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026